What is the loading dose of levetiracetam (Keppra) for adults and pediatric patients, and how should it be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Loading Dose of Levetiracetam (Keppra)

For status epilepticus in adults, administer levetiracetam 40-60 mg/kg IV (maximum 4500 mg) as a loading dose, which can be given undiluted as an IV push over 5-15 minutes or diluted over 15 minutes.

Adult Dosing

Status Epilepticus (Benzodiazepine-Refractory)

  • Loading dose: 40-60 mg/kg IV (maximum 2500-4500 mg) 1
  • Administration: Can be given as undiluted IV push over 5-15 minutes or diluted in 100 mL compatible fluid over 15 minutes 2
  • The 2019 Nature Reviews Clinical Oncology guidelines specifically recommend 40 mg/kg (maximum 2500 mg) IV bolus for both convulsive and non-convulsive status epilepticus in the CAR T-cell therapy population 1

Second-Line Agent (After Benzodiazepines)

  • 30 mg/kg IV delivered at 5 mg/kg per minute is effective, with 73% seizure cessation rates 3
  • The 2014 Annals of Emergency Medicine guideline supports levetiracetam as equally effective as fosphenytoin or valproate for benzodiazepine-refractory status epilepticus 3, 4

Standard Epilepsy Loading (Non-Emergency)

  • 1500 mg IV over 15 minutes is commonly used 3
  • FDA-approved dosing for switching from oral: equivalent to total daily oral dose 2

Pediatric Dosing

Status Epilepticus

  • 40 mg/kg IV bolus (maximum 2500 mg) 1
  • Followed by maintenance: 15-30 mg/kg IV every 12 hours depending on seizure control 1

Age-Specific Loading Doses (Non-Status)

  • 1 month to <6 months: 14 mg/kg/day divided twice daily 2
  • 6 months to <4 years: 20 mg/kg/day divided twice daily 2
  • 4 years to <16 years: 20 mg/kg/day divided twice daily 2
  • Safety data supports 50 mg/kg loading dose (maximum 2500 mg) over 15 minutes in children 5

Administration Methods

Undiluted IV Push (Preferred for Emergencies)

  • Significantly faster administration: 12 minutes vs 38-44 minutes for diluted infusion 6
  • Safe at doses up to 4500 mg given over 5-15 minutes 6, 7, 8
  • No increased adverse events compared to diluted administration 6, 7, 9, 8
  • Reduced ICU admissions in status epilepticus patients (adjusted OR 0.23) 6
  • Can be administered via peripheral IV line 7

Diluted IV Infusion (Traditional Method)

  • Dilute in 100 mL compatible diluent (0.9% NaCl, LR, D5W) 2
  • Maximum concentration: 15 mg/mL 2
  • Infuse over 15 minutes 2
  • Disadvantage: Significant drug waste (57.6% of diluted bags not administered) 9

Safety Profile

Levetiracetam has an excellent safety profile with minimal adverse effects:

  • No significant hemodynamic instability (hypotension <3.2%, bradycardia <2.3%) 4, 6
  • No cardiac arrhythmias 4
  • Minimal sedation (6-12%) 4
  • No infusion site reactions with undiluted administration 7, 9
  • Caution: Higher doses (>40 mg/kg) associated with increased intubation rates (45.8% vs 26-28%) 10

Clinical Considerations

Efficacy

  • Seizure cessation rates: 44-73% within 60 minutes for benzodiazepine-refractory status epilepticus 3, 4
  • Equivalent efficacy to fosphenytoin and valproate as second-line agents 4
  • No difference in seizure termination between 20 mg/kg, 30 mg/kg, or 40-60 mg/kg doses 10

Renal Impairment

  • Dose adjustment required in adults with CrCl <80 mL/min 2
  • Normal renal function: 500-1500 mg every 12 hours
  • Mild impairment (CrCl 50-80): 500-1000 mg every 12 hours
  • Moderate impairment (CrCl 30-50): 250-750 mg every 12 hours
  • Severe impairment (CrCl <30): 250-500 mg every 12 hours
  • ESRD on dialysis: 500-1000 mg every 24 hours with 250-500 mg supplemental dose post-dialysis 2

Common Pitfalls

  • Avoid underdosing: Doses <30 mg/kg may be less effective in status epilepticus 3
  • Don't delay for dilution: Undiluted IV push is faster and equally safe 6, 7
  • Monitor for behavioral changes: 13% of adults and 38% of pediatric patients experience behavioral symptoms with chronic use 2
  • Avoid abrupt discontinuation: Taper to reduce risk of increased seizure frequency 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.